Lesions of the lungs, trachea, and mediastinum
Conditions
Interventions
Experimental group:Remimazolam + Alfentanil
Control group:Propofol + Alfentanil
Sponsors
Affiliated Hospital of Jiangsu University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Patients undergoing elective endobronchial ultrasound examination; 2.American Society of Anesthesiologists (ASA) physical status classification ?-?; 3.Age 18-60 years; 4.Body Mass Index (BMI) 18-25 kg/m²; 5.Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Complicated with hypoxemia; 2.Inadequately controlled potentially life-threatening cardiovascular and respiratory diseases; 3.Diabetes mellitus or hepatic/renal insufficiency; 4.Severe hemostatic dysfunction; 5.Anemia; 6.Allergy to sedative/anesthetic drugs; 7.Complicated with neurological or psychiatric disorders, or those taking psychotropic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Recovery-15;Incidence of Intraoperative Respiratory Depression; | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of coughing during the induction period;Induction endpoint time;Incidence of coughing response during induction;Time of regaining consciousness;Ramsay Sedation Scale Score;Postoperative Nausea and Vomiting(PONV) Score;The satisfaction of anesthesiologists and endobronchial ultrasound operators with the anesthetic effect;Other postoperative adverse reactions;Blood pressure(BP);Heart rate(HR);Pulse oxygen saturation(SpO?); | — |
Countries
China
Contacts
Public ContactJiang Peng
Affiliated Hospital of Jiangsu University
Outcome results
None listed